FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

US Pharmaceuticals CRYO-273 Cold Pain Relieving Gel Roll-On 3 FL Recall

CRYO-273 Cold Pain Relieving Gel Roll-On 3 FL

US Pharmaceuticals Inc. · Belleville, NJ

Risk level
Class II
Reported by FDA
Aug 21, 2019
Recall ID
D-1737-2019
Check your lot numberHow we source this data

Summary

US Pharmaceuticals recalled CRYO-273 Cold Pain Relieving Gel Roll-On 3 FL starting Jul 11, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1737-2019 on Aug 21, 2019. Reason: CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process. Status: Terminated.

Why it was recalled

CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.

Product description

CRYO-273 Cold Pain Relieving Gel Roll-On 3 FL. OZ. (89 mL) Distributed By: CRYO-273.com Tampa, FL 33629. UPC 8 15290 01529 6

Lot numbers, UPCs & expiration codes

Lot #'s 09K17, 13K17 EXP 08/2019

Where it was sold

Distributed Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1737-2019
Classification
Class II
Status
Terminated
Recall initiated
Jul 11, 2019
FDA report date
Aug 21, 2019
Quantity
167 cases
Recall type
Voluntary: Firm initiated
Recalling firm
US Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-1737-2019, exactly as published.

Show all FDA fields
City
Belleville
State
NJ
Status
Terminated
Country
United States
Event ID
83316
Address
681 Main St Ste 27
Code information
Lot #'s 09K17, 13K17 EXP 08/2019
Postal code
07109-3471
Report date
Aug 21, 2019
Product type
Drugs
Recall number
D-1737-2019
Classification
Class II
Recalling firm
US Pharmaceuticals Inc.
Product quantity
167 cases
Termination date
Jun 25, 2020
Reason for recall
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
Voluntary / mandated
Voluntary: Firm initiated
Product description
CRYO-273 Cold Pain Relieving Gel Roll-On 3 FL. OZ. (89 mL) Distributed By: CRYO-273.com Tampa, FL 33629. UPC 8 15290 01529 6
Distribution pattern
Distributed Nationwide in the USA
Recall initiation date
Jul 11, 2019
Initial firm notification
Letter
Center classification date
Aug 13, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1737-2019, published Aug 21, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls